MMH-MAP

N/A

Report date: 2022/11/14 13:45:23
NME

Base Information

Drug NameMMH-MAP
Drug Alias NameMMH-MAP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIschemic StrokeCognitive DysfunctionCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesMateria Medica Holding
Inactive CompaniesN/A
Active IndicationsCognition Disorders
Inactive IndicationsIschemic StrokeCognitive Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A